» Articles » PMID: 22985037

A Review of the Scientific Evidence for Biofilms in Wounds

Overview
Date 2012 Sep 19
PMID 22985037
Citations 152
Authors
Affiliations
Soon will be listed here.
Abstract

Both chronic and acute dermal wounds are susceptible to infection due to sterile loss of the innate barrier function of the skin and dermal appendages, facilitating the development of microbial communities, referred to as biofilms, within the wound environment. Microbial biofilms are implicated in both the infection of wounds and failure of those wounds to heal. The aim of this review is to provide a summary of published papers detailing biofilms in wounds, the effect they have on infection and wound healing, and detailing methods employed for their detection. The studies highlighted within this paper provide evidence that biofilms reside within the chronic wound and represent an important mechanism underlying the observed, delayed healing and infection. The reasons for this include both protease activity and immunological suppression. Furthermore, a lack of responsiveness to an array of antimicrobial agents has been due to the biofilms' ability to inherently resist antimicrobial agents. It is imperative that effective strategies are developed, tested prospectively, and employed in chronic wounds to support the healing process and to reduce infection rates. It is increasingly apparent that adoption of a biofilm-based management approach to wound care, utilizing the "antibiofilm tool box" of therapies, to kill and prevent reattachment of microorganisms in the biofilm is producing the most positive clinical outcomes and prevention of infection.

Citing Articles

Examining the prevalence and antimicrobial resistance profiles of multidrug-resistant bacterial isolates in wound infections from Indonesian patients.

Prastiyanto M, Darmawati S, Daryono B, Retnaningrum E Narra J. 2024; 4(2):e980.

PMID: 39280315 PMC: 11394175. DOI: 10.52225/narra.v4i2.980.


Recent Advancement in Novel Wound Healing Therapies by Using Antimicrobial Peptides Derived from Humans and Amphibians.

Satapathy T, Kishore Y, Pandey R, Shukla S, Bhardwaj S, Gidwani B Curr Protein Pept Sci. 2024; 25(8):587-603.

PMID: 39188211 DOI: 10.2174/0113892037288051240319052435.


Understanding and treating diabetic foot ulcers: Insights into the role of cutaneous microbiota and innovative therapies.

Norton P, Trus P, Wang F, Thornton M, Chang C Skin Health Dis. 2024; 4(4):e399.

PMID: 39104636 PMC: 11297444. DOI: 10.1002/ski2.399.


Reactive Oxygen Species (ROS)-Mediated Antibacterial Oxidative Therapies: Available Methods to Generate ROS and a Novel Option Proposal.

Alfei S, Schito G, Schito A, Zuccari G Int J Mol Sci. 2024; 25(13).

PMID: 39000290 PMC: 11241369. DOI: 10.3390/ijms25137182.


Nanoparticle-Based Strategies for Managing Biofilm Infections in Wounds: A Comprehensive Review.

Sedighi O, Bednarke B, Sherriff H, Doiron A ACS Omega. 2024; 9(26):27853-27871.

PMID: 38973924 PMC: 11223148. DOI: 10.1021/acsomega.4c02343.